West Pharmaceutical Services (WST) Common Equity (2009 - 2026)
West Pharmaceutical Services (WST) posted Common Equity of $3.0 billion for Q2 2026, little changed sequentially from $3.0 billion in Q1 2026, and up 2.09% YoY from $2.9 billion in Q2 2025.
West Pharmaceutical Services (WST) Common Equity (2009 - 2026) Analysis & Trends
West Pharmaceutical Services has reported Common Equity for 18 years, with the latest figure at $3.0 billion in Q2 2026.
- Quarterly Common Equity rose 2.09% year-over-year to $3.0 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $3.0 billion (up 2.09% YoY) and the FY2025 annual result came in at $3.2 billion, up 18.41% from the prior year.
- Common Equity steadied at $3.0 billion in Q2 2026 per WST's latest filing, from $3.0 billion in the prior quarter.
- Over five years, Common Equity peaked at $3.2 billion in Q4 2025 and troughed at $2.3 billion in Q1 2022.
- A 5-year average of $2.8 billion and a median of $2.7 billion in 2023 frame the typical range for Common Equity.
- The sharpest annual moves came in 2022 and 2024: Common Equity grew 27.18% in 2022, then retreated 6.9% in 2024.
- Over 5 years, Common Equity stood at $2.7 billion in 2022, then increased by 7.3% to $2.9 billion in 2023, then retreated by 6.9% to $2.7 billion in 2024, then advanced by 18.41% to $3.2 billion in 2025, then dropped by 5.85% to $3.0 billion in 2026.
- According to Business Quant data, Common Equity over the past three periods registered $3.0 billion, $3.0 billion, and $3.2 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.71 Bn | 129.49 Bn | 1.96 Bn | 18.30 Bn |
| 2 | Becton Dickinson | 52.48 Bn | 51.62 Bn | 2.32 Bn | 24.42 Bn |
| 3 | Alcon | 35.70 Bn | 34.34 Bn | 1.68 Bn | 21.60 Bn |
| 4 | Resmed | 33.94 Bn | 32.47 Bn | 861.22 Mn | 6.59 Bn |
| 5 | Medline | 29.02 Bn | 26.34 Bn | 2.22 Bn | 19.08 Bn |
| 6 | West Pharmaceutical Services | 25.02 Bn | 24.58 Bn | 329.20 Mn | 2.99 Bn |
| 7 | Solventum | 15.30 Bn | 14.89 Bn | 1.29 Bn | 4.80 Bn |
| 8 | Cooper Companies | 14.85 Bn | 14.71 Bn | 735.40 Mn | 8.24 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 6.21 Bn |
| 10 | Align Technology | 11.36 Bn | 10.26 Bn | 757.43 Mn | 4.23 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.99 Bn |
| Mar 31, 2026 | 2.99 Bn |
| Dec 31, 2025 | 3.18 Bn |
| Sep 30, 2025 | 3.05 Bn |
| Jun 30, 2025 | 2.93 Bn |
| Mar 31, 2025 | 2.68 Bn |
| Dec 31, 2024 | 2.68 Bn |
| Sep 30, 2024 | 2.75 Bn |
| Jun 30, 2024 | 2.58 Bn |
| Mar 31, 2024 | 2.68 Bn |
| Dec 31, 2023 | 2.88 Bn |
| Sep 30, 2023 | 2.87 Bn |
| Jun 30, 2023 | 2.75 Bn |
| Mar 31, 2023 | 2.78 Bn |
| Dec 31, 2022 | 2.68 Bn |
| Sep 30, 2022 | 2.47 Bn |
| Jun 30, 2022 | 2.42 Bn |
| Mar 31, 2022 | 2.33 Bn |
| Dec 31, 2021 | 2.34 Bn |
| Sep 30, 2021 | 2.20 Bn |